Case-Based Roundtable Meetings Spotlight
Case-Based Roundtable Meetings Spotlight: December 2, 2021
Case-Based Roundtable Meetings Spotlight December 1, 2021
Case-Based Roundtable Meeting Spotlight November 1 2021
Case-Based Roundtable Meeting Spotlight November 2, 2021
Case-Based Roundtable Meeting Spotlight October 1 2021
Case-Based Roundtable Meeting Spotlight October 2 2021
Case-Based Roundtable Meeting Spotlight September 2021:Hematologic Malignancies
Case-Based Roundtable Meeting Spotlight September 2021: Solid Tumors
Case-Based Roundtable Meetings Spotlight August 2021: Solid Tumors
Case-Based Roundtable Meetings Spotlight August 2021: Hematologic Malignancies
Case-Based Roundtable Meetings Spotlight July 1 2021
Case-Based Roundtable Meetings Spotlight July 2 2021
Case-Based Roundtable Meetings Spotlight June 2021: Hematologic Malignancies
Case-Based Roundtable Meetings Spotlight June 2021: Solid Tumors
Case-Based Roundtable Meetings Spotlight May 2021: Solid Tumors
Case-Based Roundtable Meetings Spotlight May 2021: Hematologic Malignancies
Case-Based Roundtable Meetings Spotlight April 2, 2021
Case-Based Roundtable Meetings Spotlight April 1, 2021
Case-Based Roundtable Meetings Spotlight March 2021: Solid Tumors
Case-Based Roundtable Meetings Spotlight March 2021: Hematologic Malignancies
Case-Based Roundtable Meeting Spotlight February 2 2021
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Approves T-DXd Plus Pertuzumab for HER2-Positive Breast Cancer
2
Teclistamab/Daratumumab Earns FDA Priority Voucher for R/R Myeloma
3
Roxadustat Granted Orphan Drug Designation for Myelodysplastic Syndromes
4
Gut Health & Myeloma: How Bacteria May Predict Transplant Success With Pooja Phull, MD
5
